Inflammation and Alzheimer's disease: Possible role of periodontal diseases

Alzheimer's and Dementia

Volumn 4, Issue 4, 2008, Pages 242-250

  Kamer, Angela R ^a   Craig, Ronald G ^a   Dasanayake, Ananda P ^a   Brys, Miroslaw ^b   Glodzik Sobanska, Lidia ^b   de Leon, Mony J ^b,c  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Alzheimer's disease; Inflammation; Pathogenesis model; Periodontitis

Indexed keywords

AMYLOID BETA PROTEIN; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;

AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOOD BRAIN BARRIER; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GENETIC POLYMORPHISM; GENETIC RISK; HIGH RISK PATIENT; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LOW DRUG DOSE; NONHUMAN; PATHOGENESIS; PERIODONTAL DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; RISK REDUCTION;

ALZHEIMER DISEASE; DISEASE PROGRESSION; HUMANS; INFLAMMATION; PERIODONTAL DISEASES; RISK FACTORS;

EID: 45749107101     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2007.08.004     Document Type: Article

References (50)

1. Nee L.E., and Lippa C.F. Alzheimer's disease in 22 twin pairs: 13-year follow-up-hormonal, infectious and traumatic factors. Dement Geriatr Cogn Disord 10 (1999) 148-151
2. McGeer P.L., and McGeer E.G. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22 (2001) 799-809
3. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
4. Konsman J.P., Drukarch B., and Van Dam A.M. (Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. Clin Sci (Lond) 112 (2007) 1-25
5. Gosselin D., and Rivest S. Role of IL-1 and TNF in the brain: twenty years of progress on a Dr Jekyll/Mr Hyde duality of the innate immune system. Brain Behav Immun 21 (2007) 281-289
6. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol 61 (2004) 668-672
7. Yaffe K., Kanaya A., Lindquist K., Simonsick E.M., Harris T., Shorr R.I., et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292 (2004) 2237-2242
8. Schmidt R., Schmidt H., Curb J.D., Masaki K., White L.R., and Launer L.J. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52 (2002) 168-174
9. Kalman J., Juhasz A., Laird G., Dickens P., Jardanhazy T., Rimanoczy A., et al. Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol Scand 96 (1997) 236-240
10. Holmes C., El-Okl M., Williams A.L., Cunningham C., Wilcockson D., and Perry V.H. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 74 (2003) 788-789
11. Nicoll J.A., Mrak R.E., Graham D.I., Stewart J., Wilcock G., MacGowan S., et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 47 (2000) 365-368
12. in't Veld B.A., Ruitenberg A., Hofman A., Stricker B.H., and Breteler M.M. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 22 (2001) 407-412
13. Stewart W.F., Kawas C., Corrada M., and Metter E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48 (1997) 626-632
14. McGeer P.L., and McGeer E.G. Anti-inflammatory drugs in the fight against Alzheimer's disease. Ann N Y Acad Sci 777 (1996) 213-220
15. Aisen P.S., Schafer K.A., Grundman M., Pfeiffer E., Sano M., Davis K.L., et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289 (2003) 2819-2826
16. Thal L.J., Ferris S.H., Kirby L., Block G.A., Lines C.R., Yuen E., et al. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 30 (2005) 1204-1215
17. Townsend K.P., and Pratico D. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. Faseb J 19 (2005) 1592-1601
18. von Bernhardi R., and Eugenin J. Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res 1025 (2004) 186-193
19. Dantzer R., Konsman J.P., Bluthe R.M., and Kelley K.W. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent?. Auton Neurosci 85 (2000) 60-65
20. Miller A.J., Luheshi G.N., Rothwell N.J., and Hopkins S.J. Local cytokine induction by LPS in the rat air pouch and its relationship to the febrile response. Am J Physiol 272 Pt 2 (1997) R857-R861
21. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav Immun 17 (2003) 13-19
22. Itzhaki R.F., Wozniak M.A., Appelt D.M., and Balin B.J. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 25 (2004) 619-627
23. Lerner A.J., Hedera P., Koss E., Stuckey J., and Friedland R.P. Delirium in Alzheimer disease. Alzheimer Dis Assoc Disord 11 (1997) 16-20
24. Balin B.J., Gerard H.C., Arking E.J., Appelt D.M., Branigan P.J., Abrams J.T., et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol (Berl) 187 (1998) 23-42
25. Miklossy J., Kis A., Radenovic A., Miller L., Forro L., Martins R., et al. Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging 27 (2006) 228-236
26. Ellen R.P., and Galimanas V.B. Spirochetes at the forefront of periodontal infections. Periodontol 2000 38 (2005) 13-32
27. Riviere G.R., Riviere K.H., and Smith K.S. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol Immunol 17 (2002) 113-118
28. Foschi F., Izard J., Sasaki H., Sambri V., Prati C., Muller R., et al. Treponema denticola in disseminating endodontic infections. J Dent Res 85 (2006) 761-765
29. Taubman M.A., Valverde P., Han X., and Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 76 Suppl (2005) 2033-2041
30. Albandar J.M. Periodontal diseases in North America. Periodontol 2000 29 (2002) 31-69
31. Socransky S.S., and Haffajee A.D. Dental biofilms: difficult therapeutic targets. Periodontol 2000 28 (2002) 12-55
32. Kornman K.S., Page R.C., and Tonetti M.S. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 14 (1997) 33-53
33. Kornman K.S. Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr 83 (2006) 475S-483S
34. Scannapieco F.A., Bush R.B., and Paju S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease: a systematic review. Ann Periodontol 8 (2003) 54-69
35. Zijlstra E.E., Swart G.R., Godfroy F.J., and Degener J.E. Pericarditis, pneumonia and brain abscess due to a combined Actinomyces-Actinobacillus actinomycetemcomitans infection. J Infect 25 (1992) 83-87
36. Dasanayake A.P., Russell S., Boyd D., Madianos P.N., Forster T., and Hill E. Preterm low birth weight and periodontal disease among African Americans. Dent Clin North Am 47 (2003) 115-125 x-xi
37. Beck J.D., and Offenbacher S. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 76 Suppl (2005) 2089-2100
38. Taylor G.W. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol 6 (2001) 99-112
39. Gatz M.M.J., Fratiglioni L., Johansson B., Berg S., Reynolds C.A., and Pedersen N.L. Potentially modifiable risk factors for dementia in identical twins. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 2 (2006) 110-117
40. Lucas V., and Roberts G.J. Odontogenic bacteremia following tooth cleaning procedures in children. Pediatr Dent 22 (2000) 96-100
41. Okuda K., Ishihara K., Nakagawa T., Hirayama A., Inayama Y., and Okuda K. Detection of Treponema denticola in atherosclerotic lesions. J Clin Microbiol 39 (2001) 1114-1117
42. Pussinen P.J., Jousilahti P., Alfthan G., Palosuo T., Asikainen S., and Salomaa V. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol 23 (2003) 1250-1254
43. Desvarieux M., Demmer R.T., Rundek T., Boden-Albala B., Jacobs Jr. D.R., Sacco R.L., et al. Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111 (2005) 576-582
44. Ide M., Jagdev D., Coward P.Y., Crook M., Barclay G.R., and Wilson R.F. The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. J Periodontol 75 (2004) 420-428
45. Craig R.G., Yip J.K., So M.K., Boylan R.J., Socransky S.S., and Haffajee A.D. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 74 (2003) 1007-1016
46. Slade G.D., Offenbacher S., Beck J.D., Heiss G., and Pankow J.S. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 79 (2000) 49-57
47. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1 (1996) 821-878
48. McGeer E.G., and McGeer P.L. Innate immunity in Alzheimer's disease: a model for local inflammatory reactions. Mol Interv 1 (2001) 22-29
49. McGeer P.L., and McGeer E.G. NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 28 (2007) 639-647
50. de Leon M.J., DeSanti S., Zinkowski R., Mehta P.D., Pratico D., Segal S., et al. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging 27 (2006) 394-401